Targeting Apollo-NADP


Journal

ACS sensors
ISSN: 2379-3694
Titre abrégé: ACS Sens
Pays: United States
ID NLM: 101669031

Informations de publication

Date de publication:
25 11 2022
Historique:
pubmed: 22 10 2022
medline: 29 11 2022
entrez: 21 10 2022
Statut: ppublish

Résumé

NADPH/NADP

Identifiants

pubmed: 36269889
doi: 10.1021/acssensors.2c01174
pmc: PMC9706804
doi:

Substances chimiques

NADP 53-59-8
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3308-3317

Références

Biosens Bioelectron. 2016 Mar 15;77:901-6
pubmed: 26524720
Biophys J. 1996 Jul;71(1):194-208
pubmed: 8804603
Microbiology (Reading). 2009 Jan;155(Pt 1):268-278
pubmed: 19118367
APL Bioeng. 2021 Jan 04;5(1):016101
pubmed: 33415313
Bioeng Transl Med. 2020 Sep 08;5(3):e10184
pubmed: 33005744
Antioxid Redox Signal. 2008 Feb;10(2):179-206
pubmed: 18020963
J Biol Chem. 2007 Jan 5;282(1):200-7
pubmed: 17102138
Mol Aspects Med. 2009 Feb-Apr;30(1-2):77-85
pubmed: 19232542
J Biol Chem. 1997 Jul 25;272(30):18572-9
pubmed: 9228023
Biophys J. 2003 Jun;84(6):4078-86
pubmed: 12770911
Proc Natl Acad Sci U S A. 1992 May 15;89(10):4412-6
pubmed: 1584774
J Histochem Cytochem. 2007 Feb;55(2):175-81
pubmed: 17101723
Nat Methods. 2016 Apr;13(4):352-8
pubmed: 26878383
Mol Metab. 2014 Sep 28;3(9):848-54
pubmed: 25506550
Adv Genet. 1999;41:95-156
pubmed: 10494618
Biophys J. 2012 Dec 5;103(11):2379-88
pubmed: 23283237
J Biol Chem. 2001 Dec 28;276(52):48748-53
pubmed: 11641408
Biochem J. 1969 Dec;115(4):609-19
pubmed: 4391039
J Biol Chem. 1999 Oct 22;274(43):30527-33
pubmed: 10521434
Elife. 2018 Jul 03;7:
pubmed: 29968564
Neurochem Res. 2019 Jan;44(1):117-132
pubmed: 29079932
Cell Rep. 2017 Mar 14;18(11):2592-2599
pubmed: 28297664
Sci Rep. 2022 Apr 12;12(1):6110
pubmed: 35414066
Biochim Biophys Acta. 2006 May-Jun;1757(5-6):721-6
pubmed: 16730324
Cell Metab. 2021 Apr 6;33(4):804-817.e5
pubmed: 33321098
J Biol Chem. 2012 Jun 8;287(24):19997-20006
pubmed: 22523080
J Biol Chem. 2006 Oct 13;281(41):30593-602
pubmed: 16912049
Methods Mol Biol. 2010;637:311-31
pubmed: 20419443
Neurosci Lett. 1999 Nov 12;275(2):97-100
pubmed: 10568508
Elife. 2018 May 29;7:
pubmed: 29809136
J Biol Chem. 1995 Aug 25;270(34):20051-8
pubmed: 7650022
Eur J Biochem. 1989 Jul 15;183(1):75-82
pubmed: 2753047
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6803-8
pubmed: 9618493
Mol Cell Endocrinol. 2009 Mar 25;301(1-2):137-41
pubmed: 18778749
J Biol Chem. 1976 Mar 10;251(5):1364-70
pubmed: 176149
Int J Mol Sci. 2015 Jun 30;16(7):14695-716
pubmed: 26133241
Nat Metab. 2021 Apr;3(4):571-585
pubmed: 33833463
Diabetologia. 2007 Dec;50(12):2476-85
pubmed: 17922105
Int J Cell Biol. 2012;2012:273947
pubmed: 22675360
Arch Biochem Biophys. 1977 Nov;184(1):222-36
pubmed: 21628
Biochem J. 1987 Jan 1;241(1):161-7
pubmed: 3551925
Diabetologia. 2005 Apr;48(4):675-86
pubmed: 15729571
Biophys J. 1979 Jun;26(3):557-73
pubmed: 263688
Mol Cell Endocrinol. 2019 Feb 5;481:71-83
pubmed: 30476561
Nat Methods. 2017 Jul;14(7):720-728
pubmed: 28581494
Biochem J. 1987 Jun 1;244(2):443-8
pubmed: 2822005
J Cell Biol. 1989 May;108(5):1657-64
pubmed: 2654139
Eur J Biochem. 1972 Dec 18;31(3):496-504
pubmed: 4405493
Nat Commun. 2012 Mar 20;3:751
pubmed: 22434194
ACS Sens. 2022 Nov 25;7(11):3308-3317
pubmed: 36269889
J Biol Chem. 2018 Nov 2;293(44):17218-17228
pubmed: 30217817
Diabetes. 2006 Jul;55(7):2153-6
pubmed: 16804088
Nat Methods. 2019 Apr;16(4):277-278
pubmed: 30886412
J Biol Chem. 2011 Apr 1;286(13):11672-84
pubmed: 21224385
Chem Biol. 2000 Mar;7(3):197-209
pubmed: 10712929

Auteurs

Huntley H Chang (HH)

Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.
Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario M5G 2C4, Canada.

Alex M Bennett (AM)

Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.
Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario M5G 2C4, Canada.

William D Cameron (WD)

Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.
Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario M5G 2C4, Canada.

Eric Floro (E)

Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.
Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario M5G 2C4, Canada.

Aaron Au (A)

Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.

Christopher M McFaul (CM)

Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.

Christopher M Yip (CM)

Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.

Jonathan V Rocheleau (JV)

Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.
Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario M5G 2C4, Canada.
Department of Physiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
Banting and Best Diabetes Centre, University of Toronto, Toronto, Ontario M5G 2C4, Canada.

Articles similaires

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis

A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemia.

Lisa Demoen, Filip Matthijssens, Lindy Reunes et al.
1.00
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Animals Mice Humans Cell Line, Tumor
Adenosine Triphosphate Adenosine Diphosphate Mitochondrial ADP, ATP Translocases Binding Sites Mitochondria

High mitochondrial DNA levels accelerate lung adenocarcinoma progression.

Mara Mennuni, Stephen E Wilkie, Pauline Michon et al.
1.00
DNA, Mitochondrial Animals Adenocarcinoma of Lung Disease Progression Mice

Classifications MeSH